Agents with a dominant or highly significant nicotinergic pathway(s) modulating mechanism of action
Alsevetin-OA (TLR-6124) is an optimized agent expressing potent alpha7 NAChR partial agonist activity with moderate efficacy and a high therapeutic index, devoid of tolerance inducing effects. Indications for focus/ADHD, nootropic, anti-addiction, analgesic-sparing research.
NICX-OX Nicotine Cessation Optimized Xtract - Optimized Herbal Extract Formulation to Promote Nicotine Cessation Selectively Modulates Key Nicotinic Receptor Subtypes for Optimized Nicotine Cessation. Research Indications: Addiction Research and Nicotine Cessation